MBX vs RARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 26, 2026

MBX

46.5
AI Score
VS
RARE Wins

RARE

53.5
AI Score

Investment Advisor Scores

MBX

47score
Recommendation
HOLD

RARE

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MBX RARE Winner
Net Income -60.61M -575.00M MBX
Operating Income -68.20M -535.00M MBX
ROE -14.8% 718.8% RARE
ROA -13.9% -37.5% MBX
Total Assets 435.91M 1.53B RARE
Cash 54.12M 421.00M RARE
Current Ratio 18.08 2.48 MBX
Free Cash Flow -44.17M -472.00M MBX

Relative Price Performance (Last 90 Days)

MBX 1M: +11.9% · 3M: +116.1% RARE 1M: -1.6% · 3M: +14.3%

Current Technical Phase

MBX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (30.9% over 20 days), RSI 60

RSI (14): 60.2 · Price: $68.62

RARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $26.46

Fundamentals Snapshot

Metric MBX RARE
Market Cap
Forward P/E -17.4 39.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin -0.2%
Operating Margin 0.0% -0.4%
EPS -2.37 -5.80
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RARE is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.